Treatment Options for Patients With Chronic Myeloid Leukemia Who Are Resistant to or Unable to Tolerate Imatinib
Clinical Therapeutics - United States
doi 10.1016/j.clinthera.2010.05.003
Full Text
Open PDFAbstract
Available in full text
Categories
Date
May 1, 2010
Authors
Publisher
Elsevier BV